ALT EXAMPLE - ANNUAL REPORT - LARTA INSTITUTE - Flipbook - Página 28
THE HUMANE SOLUTION, SENESTECH
RECEIVED TIBBETTS AWARD
THE UP AND COMER, OPUS 12
GIVEN TO ONLY 23 SMALL
BUSINESSES AND SIX
AWARD FOR WINNING
INDIVIDUALS FOR THEIR
“GLOBAL CHANGE THE WORLD”
EXEMPLARY ROLES IN THE
COMPETITION AS PART OF
SMALL BUSINESS INNOVATION
FORBES 30 UNDER 30 SUMMIT
RESEARCH (SBIR) AND SMALL
Women-Owned Business
Industry: Life Sciences/Healthcare
Technology: ContraPest®
Larta Program: NIH CAP 2008-2009
Ag Innovation Showcase 2013
BUSINESS TECHNOLOGY
TRANSFER (STTR) PROGRAM
EPA APPROVED CONTRAPEST®
$425K
Women-led Business
Industry: Cleantech/Energy
Technology: CO2 utilization technology
that recycles carbon dioxide into fuels
and chemicals
Larta Program: NSF-CAP 2016B
SELECTED TO JOIN BREAKOUT
LABS, RUN BY THE THIEL
FOUNDATION
TECHNOLOGY
“Because of Larta, I’ve grown from an innovator to the president of a public company. Larta
showed me how to take my innovation and fly
to the moon with it.”
LORETTA MAYER, CEO AND CO-FOUNDER, SENESTECH
Q+A:
Loretta Mayer
CEO and Co-Founder
What is your company’s technology?
We specialize in humane animal population management through fertility control.
Rodents reproduce faster than we can eliminate them. ContraPest®, our non-lethal
compound, is placed in a liquid bait that triggers infertility in rodents, with no
negative impact on other animal species, humans, or the environment.
What sets your company apart from the competition?
There has been no innovation in rodent control since the Middle Ages. Our product
is the first and only of its kind. Instead of elimination, we disrupt reproduction
and dramatically reduce rodent populations.
What was Larta’s impact on your company?
Primary drivers that I connected with at Ag Innovation Showcase helped me
grow my company to where it is today. If you want to jump into the deep end
of the entrepreneurship pool, you want the Larta life vest on.
LORETTA
MAYER
COMPANY PROFILES
25
CEO AND CO-FOUNDER, SENESTECH
COMPANY IS REGISTERED IN
15 U.S. STATES
BEGAN REGISTRATION IN
THE EUROPEAN UNION
$15M
RAISED GOING PUBLIC UNDER
THE SYMBOL SNES
“SENESTECH SAW OPPORTUNITY WHERE OTHER
COMPANIES WOULD HAVE
MISSED IT. LARTA HELPED
THEM TO COMMERCIALIZE
THEIR VISION.”
“Larta provided what our company needed in
order to reach successful commercialization.”
ADVANCED TO SEMIFINALS OF
THE NRG CARBON XPRIZE
ETOSHA CAVE, CO-FOUNDER, OPUS 12
Q+A:
“OPUS 12 IS MOVING QUICKLY
Etosha Cave
Co-Founder
What is your company’s technology?
Our device bolts onto any source of carbon dioxide emissions and with only water
and electricity as inputs, transforms CO2 into some of the world’s most critical
chemical products. We reduce costs by 40%-70%, maintain a high purity level of
carbon monoxide, and enable a more environmentally-friendly supply of carbon
monoxide.
TOWARD THE MARKETPLACE.
THEY HAVE A GIFT FOR COMMUNICATING THEIR VISION, AND AS
A RESULT, THEY ARE ADVANCED
IN RAISING VENTURE CAPITAL
MONEY.”
JOHN TAO, LARTA PRINCIPAL ADVISOR
What sets your company apart from the competition?
Because our device is aimed at small- and medium-scale carbon monoxide users,
we have a niche market entry and a $300 billion global opportunity. We effectively
cut out expensive middleman gas delivery companies and provide onsite, costeffective, and highly pure CO.
What was Larta’s impact on your company?
Larta paired us with PA John Tao who has specific knowledge of and experience in
specialty gas manufacturing. John’s mentorship was essential to our startup’s success.
VIVIAN DULLIEN
LARTA PRINCIPAL ADVISOR
XX
26